Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Roles of sulfhydryl and disulfide groups in the binding of CP-55,940 to rat brain cannabinoid receptor


The roles of sulfhydryl and disulfide groups in the specific binding of synthetic cannabinoid CP-55,940 to the cannabinoid receptor in membrane preparations from the rat cerebral cortex have been examined. Various sulfhydryl blocking reagents including p-chloromercuribenzoic acid (p-CMB), N-ethylmaleimide (NEM), o-iodosobenzoic acid (o-ISB), and methyl methanethiosulfonate (MMTS) inhibited the specific binding of [3H]CP-55,940 to the cannabinoid receptor in a dose-dependent manner. About 80–95% inhibition was obtained at a 0.1 mM concentration of these reagents. Scatchard analysis of saturation experiments indicates that most of these sulfhydryl modifying reagents reduce both the binding affinity (Kd) and capacity (Bmax). On the other hand, DL-dithiothreitol (DTT), a disulfide reducing agent, also irreversibly inhibited the specific binding of [3H]CP-55,940 to the receptor and about 50% inhibition was obtained at a 5 mM concentration. Furthermore, 5mM DTT was abelt to dissociate 50% of the bound ligand from the ligand-receptor complex. The marked inhibition of [3H]CP-55,940 binding by sulfhydryl reagents suggests that at least one free sulfhydryl group is essential to the binding of the ligand to the receptor. In addition, the inhibition of the binding by DTT implies that besides free sulfhydryl group(s), the integrity of a disulfide bridge is also important for [3H]CP-55,940 binding to the cannabinoid receptor.

This is a preview of subscription content, log in to check access.


  1. 1.

    Dewey WL: Cannabinoid pharmacology. Pharmacol Rev 38: 151–178, 1986

  2. 2.

    Hollister LE: Health aspects of cannabis. Pharmacol Rev 38: 1–20, 1986

  3. 3.

    Martin BR: Cellular effects of cannabinoids. Pharmacol Rev 38: 45–74, 1986

  4. 4.

    Snyder SH: Planning for serendipity. Nature 346: 508, 1990

  5. 5.

    Devane WA, Dysarz FA, III, Johnson MR, Melvin LS, Howlett AC: Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34: 605–613, 1988

  6. 6.

    Howlett AC, Champion-Dorow TM, McMahon LL, Westlake TM: The cannabinoid receptor: biochemical and cellular properties in neuroblastoma cells. Pharmacol Biochem Behav 40 565–569, 1991

  7. 7.

    Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561–564, 1990

  8. 8.

    Means GE, Feeney RE: Chemical Modification of Proteins. Holden-Day, San Francisco 1971

  9. 9.

    Brocklehurst K: Specific covalent modification of thiols: applications in the study of enzymes and other biomolecules. Int J Biochem 10: 259–274, 1979

  10. 10.

    Torchinsky YM: Sulfur in Proteins. Pergamon Press, New York, 1981

  11. 11.

    Strauss WL: Sulfhydryl groups and disulfide bonds: modification of amino acid residues in studies of receptor structure and function. In: JC Venter, LC Harrison (eds). Membranes, Detergents, and Receptor Solubilization, pp 85–97. Alan R. Liss, New York, 1984

  12. 12.

    Aronstam RS, Abood LG, Hoss W: Influence of sulfhydryl reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain. Mol Pharmacol 14: 575–586, 1978

  13. 13.

    Barrantes JF: Modulation of acetylcholine receptor states by thiol modification. Biochemistry 19: 2957–2965, 1980

  14. 14.

    Stitzel JA, Campbell SM, Collins AC, Marks MJ: Sulfhydryl modification of two nicotinic binding sites in mouse brain. J Neurochem 50: 920–928, 1988

  15. 15.

    Fonseca MI, Lunt GG, Aguilar JS: Inhibition of muscarinic cholinergic receptors by disulfide reducing agents and arsenicals. Differential effect on locust and rat. Biochem Pharmacol 41: 735–742, 1991

  16. 16.

    Kilpatrick BF, De Lean A, Caron MG: Dopamine receptor of the porcine anterior pituitary gland. Effects of N-ethylmaleimide and heat on ligand binding mimic the effects of guanine nucleotides. Mol Pharmacol 22: 298–303, 1982

  17. 17.

    Sidhu A, Kassis S, Kebabian J, Fishman PH: Sulfhydryl group(s) in the ligand binding site of the D-1 dopamine receptor: specific protection by agonist and antagonist. Biochemistry 25: 6695–6701, 1986

  18. 18.

    Braestrup C, Andersen PH: Effects of heavy metal cations and other sulfhydryl reagents on brain dopamine D1 receptors: evidence for involvement of a thiol group in the conformation of the active site. J Neurochem 48: 1667–1672, 1987

  19. 19.

    Dewar KM, Reader TA: Specific [3H]SCH23390 binding to dopamine D1 receptors in cerebral cortex and neostriatum: role of disulfide and sulfhydryl groups. J Neurochem 52: 472–482, 1989

  20. 20.

    Chazot PL, Strange PG: Importance of thiol groups in ligand binding to D2 dopamine receptors from brain and anterior pituitary gland. Biochem J 281: 377–380, 1992

  21. 21.

    Reader TA, Brière R: Evidence for the participation of disulfide and sulfhydryl groups in the specific binding of [3H]prazosin in cerebral cortex. Neurochem Res 10: 107–122, 1985

  22. 22.

    Reader TA, Brière R, Grondin L: Alpha-1 and Alpha-2 adrenoceptor binding in cerebral cortex: role of disulfide and sulfhydryl groups. Neurochem Res 11: 9–27, 1986

  23. 23.

    Parini A, Homcy CJ, Graham RM: Structural properties of the α1-adrenergic receptor: studies with membrane and purified receptor preparations. Circ Res 61 (suppl. I): I100-I104, 1987

  24. 24.

    Liebl B, Anhaupl T, Haen E, Remien J: Effect of thiols on β2-adrenergic in human mononuclear leucocytes. Naunyn Schmiedebergs Arch Pharmacol 338: 523–528, 1988

  25. 25.

    Dohlman HG, Caron MG, DeBlasi A, Frielle T, Lefkowitz RJ: Role of extracellular disulfide-bonded cysteines in the ligand binding function of the β2-adrenergic receptor. Biochemistry 29: 2335–2342, 1990

  26. 26.

    Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254, 1976

  27. 27.

    Scatchard G: The attraction of proteins for small molecules and ions. Ann N Y Acad Sci 51: 660–672, 1949

  28. 28.

    Houston DB, Evans DM, Howlett AC, Melvin LS:[3H]CP-55,940 binding to the cannabinoid receptor in brain. Du Pont Biotech Update 6: 21–27, 1991

  29. 29.

    Kitamura Y, Imai S, Matsueda R, Nomura Y: Effects of sulfhydrylmodifying reagents, 3-nitro-2-pyridinesulfenyl compounds, on the coupling between inhibitory receptors and GTP-binding proteins Gi/Go in rat brain membranes. Mol Pharmacol 38: 184–191, 1990

  30. 30.

    Stratford CA, Tan GL, Hamblin MW, Ciaranello RD: Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain. Mol Pharmacol 34: 527–536, 1988

  31. 31.

    Pávó I, Fahrenholz F: Differential inactivation of vasopressin receptor subtypes in isolated membranes and intact cells by N-ethylmaleimide. FEBS 272: 205–208, 1990

  32. 32.

    Mohini P, Bahouth SW, Brundish DE, Musacchio JM: Specific labeling of rat brain substance P receptor with [3H]physalaemin. J Neurosci 5: 2078–2085, 1985

  33. 33.

    Sharma PM, Musacchio JM: N-ethylmaleimide blocks the modulatory effects of divalent cations and guanine nucleotides on the brain substance P receptor. Eur J Pharmacol 138: 9–19, 1987

  34. 34.

    Ng DS, Wong K: Effect of sulfhydryl reagents on PAF binding to human neutrophils and platelets. Eur J Pharmacol 154: 47–52, 1988

  35. 35.

    Falcone RC, Aharony D: Modulation of ligand binding to leukotriene B4 receptors on guinea pig lung membranes by sulfhydryl modifying reagents. J Pharmacol Exp Ther 255: 565–571, 1990

  36. 36.

    Santa-Coloma TA, Grasso P, Reichert LE Jr: Sulfhydryl groups are involved in the interaction of FSH with its receptor. Biochem Biophys Res Comm: 1256–1261, 1991

  37. 37.

    Huang M, Rorstad OP: Effects of GTP analogs and dithiothreitol on the binding properties of the vascular vasoactive intestinal peptide receptor. Can J Physiol Pharmacol 67: 851–856, 1989

  38. 38.

    Gehlert DR, Gackenheimer SL, Schober DA: Angiotensin II receptor subtypes in rat brain: dithiothreitol inhibits ligand binding to AII-1 and enhances binding to AII-2. Brain Res 546: 161–165, 1991

  39. 39.

    Speth RC, Rowe BP, Grove KL, Carter MR, Saylor D: Sulfhydryl reducing agents distinguish two subtypes of angiotensin II receptors in the rat brain. Brain Res 548: 1–8, 1991

  40. 40.

    Herington AC: Effect of disulfide-bond reducing agents on the specific binding of growth hormone to microsomal membrane preparations from rabbit liver. Biochem Pharmacol 35: 1359–1364, 1986

  41. 41.

    Pasternak GW, Wilson HA, Snyder SH: Differential effects of protein-modifying reagents on receptor binding of opiate agonists and antagonists. Mol Pharmacol 11: 340–351, 1975

  42. 42.

    Nozaki M, Cho TM: Effects of 5,5′-dithiobis(2-nitrobenzoic acid) on opiate binding to both membrane-bound receptor and partially purified opiate receptor. J Neurochem 45: 461–464, 1985

  43. 43.

    Nozaki M, Niwa M, Fujimura H: Comparative properties of SH-groups at mu, delta and kappa opioid receptor. NIDA Res Monogr 75: 149–152, 1986

  44. 44.

    Kamikubo K, Murase H, Murayama M, Matsuda M, Miura K: Evidence for Disulfide bonds in membrane-bound and solubilized opioid receptors. J Biochem 50: 503–509, 1988

  45. 45.

    Gioannini TL, Liu YF, Park YH, Hiller JM, Simon EJ: Evidence for the presence of disulfide bridges in opioid receptors essential for ligand binding. Possible role in receptor activation. J Mol Recognit 2: 44–48, 1989

  46. 46.

    Stadel JM, Lefkowitz RJ: Multiple reactive sulfhydryl groups modulate the function of adenylate cyclase coupledbeta-adrenergic receptors. Mol Pharmacol 16: 709–718, 1979

  47. 47.

    Pike LJ, Eakes AT, Krebs EG: Characterization of affinity-purified receptor kinase. J Biol Chem 261: 3782–3789, 1986

  48. 48.

    Douen AG, Jones MN: The role of insulin receptor sulfhydryl groups in insulin binding and cellular response in rat adipocytes. J Recept Res 10: 45–59, 1990

  49. 49.

    Sharif NA, Burt DR: Sulfhydryl groups in receptor binding of thyrotropin-releasing hormone to rat amygdala. J Neurochem 42: 209–214, 1984

Download references

Author information

Correspondence to Mohammed Y. Kalimi.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lu, R., Hubbard, J.R., Martin, B.R. et al. Roles of sulfhydryl and disulfide groups in the binding of CP-55,940 to rat brain cannabinoid receptor. Mol Cell Biochem 121, 119–126 (1993). https://doi.org/10.1007/BF00925970

Download citation

Key words

  • sulfhydryl group
  • disulfide group
  • cannabinoid receptor
  • rat cerebral cortex